Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis: A Narrative Review
Common changes includes anosmia (loss of smell), parosmia (where pleasant scents smell bad or chemical) and parageusia (where things taste wrong, or there is a phantom flavor when youre not tasting anything) as well as other and unspecified changes
Do 2021 r
This results in improved blood sugar levels and enhanced satisfaction from meals
MHRA-licensed alternatives for weight management including semaglutide (Wegovy), liraglutide (Saxenda), orlistat, and tirzepatide (Mounjaro) have well-characterised safety profiles and NICE eligibility criteria
This medications safety profile has not been studied in patients under the age of 18, pregnant and lactating people, or those with normal BMIs. At the time of publishing, the FDA has only approved three GLP-1 agonists for weight loss: Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)